A Pan-Cancer Bioinformatic Analysis of β1-Integrin–Wnt/β-Catenin Crosstalk and Its Potential Therapeutic Relevance
GISTU Journal of Health and Biological Sciences · 2025
DOI: 10.65308/gjohbs.2025.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift GISTU Journal of Health and Biological Sciences, 2025. Verfasst von Seçil Eroğlu und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Understanding adhesion receptor signalling dysregulation in cancer settings is vital for the effective and safe incorporation of adhesion-targeted therapeutics in the clinic. β1-integrin is a major extracellular matrix adhesion receptor that has been shown to control important processes such as proliferation, cell cycle progression, apoptosis and cell migration. β1-integrin signalling pathway is complex and can crosstalk with many tumorigenic pathways. It is therefore not surprising that enhanced β1-integrin signalling has been reported to correlate with progression and therapy resistance in many types of cancers. Therefore, a complete understanding of the pathways and genes altered in all cancer types is essential to identify novel therapeutic options specific for certain cancer types. In this study, a pan-cancer analysis was performed to identify alterations of β1-integrin and most dysregulated cancer-related genes (106 genes, Kegg map05200) using 2565 patients whole genomes data (ICGC/TCGA, 2020). OncoPrint, mutations, copy number alterations (CNA), mutual exclusivity and pathway enrichment were conducted using cBioPortal. PathwayMapper, an interactive graphical editing tool allowing collaborative curation was used to view altered genes and pathways with alteration frequencies. Pathway enrichment analyses related to genetic alterations identified the Wnt signaling was the most frequently altered pathway. Mutual exclusivity analyses showed that β1-integrin-Wnt; β1-integrin-LRP5/LRP6 and β1-integrin-FZD pairs exhibited co-occurrence, two sided fisher exact test indicates p < 0.001. This has shown a link between β1-integrin and Wnt/β-catenin pathways. Genetic alterations of β1-integrin receptor, whether these mutations will cause an activation of the Wnt/β-catenin pathway and their effects on overall survival and metastasis will be further examined.
Zitieren
APA
Eroğlu, S., Olabi, S., & Ekmekcigil, O. B. (2025). A Pan-Cancer Bioinformatic Analysis of β1-Integrin–Wnt/β-Catenin Crosstalk and Its Potential Therapeutic Relevance. GISTU Journal of Health and Biological Sciences. https://doi.org/10.65308/gjohbs.2025.008
Vancouver
Eroğlu S, Olabi S, Ekmekcigil OB. A Pan-Cancer Bioinformatic Analysis of β1-Integrin–Wnt/β-Catenin Crosstalk and Its Potential Therapeutic Relevance. GISTU Journal of Health and Biological Sciences. 2025. doi:10.65308/gjohbs.2025.008
BibTeX
@article{Erolu2025,
author = {Eroğlu, Seçil and Olabi, Safiah and Ekmekcigil, Oznur Bayraktar},
title = {A Pan-Cancer Bioinformatic Analysis of β1-Integrin–Wnt/β-Catenin Crosstalk and Its Potential Therapeutic Relevance},
journal = {GISTU Journal of Health and Biological Sciences},
year = {2025},
doi = {10.65308/gjohbs.2025.008}
}
EUVIMED